German Growth Stocks With High Insider Ownership For October 2024

Simply Wall St.
2024-10-08

As geopolitical tensions in the Middle East have caused fluctuations in global markets, Germany's DAX index has not been immune, experiencing a decline of 1.81% amid investor caution. However, with expectations of an interest rate cut by the European Central Bank due to slowing growth and inflation below target levels, there may be opportunities for growth-oriented investors to consider companies with significant insider ownership as a potential indicator of confidence and alignment with shareholder interests.

Top 10 Growth Companies With High Insider Ownership In Germany

Name Insider Ownership Earnings Growth
Stemmer Imaging (XTRA:S9I) 25% 23.2%
Exasol (XTRA:EXL) 25.3% 117.1%
Deutsche Beteiligungs (XTRA:DBAN) 39.5% 54.1%
adidas (XTRA:ADS) 16.6% 41.8%
pferdewetten.de (XTRA:EMH) 20.6% 97.9%
Alelion Energy Systems (DB:2FZ) 37.4% 106.6%
R. STAHL (XTRA:RSL2) 37.9% 59.3%
Friedrich Vorwerk Group (XTRA:VH2) 18.8% 24.6%
Redcare Pharmacy (XTRA:RDC) 17.4% 54.4%
Your Family Entertainment (DB:RTV) 17.3% 124.4%

Click here to see the full list of 19 stocks from our Fast Growing German Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

adidas

Simply Wall St Growth Rating: ★★★★★☆

Overview: adidas AG, along with its subsidiaries, is engaged in designing, developing, producing, and marketing athletic and sports lifestyle products across Europe, the Middle East, Africa, North America, Greater China, the Asia-Pacific region, and Latin America with a market cap of €42.55 billion.

Operations: The company's revenue is generated from various regions, including Greater China (€3.26 billion), Latin America (€2.39 billion), and North America (€5.07 billion).

Insider Ownership: 16.6%

Earnings Growth Forecast: 41.8% p.a.

adidas AG demonstrates strong growth potential, with earnings projected to grow significantly at 41.8% annually, outpacing the German market's 20.2%. Recent financial results show improved performance, with Q2 sales rising to €5.82 billion and net income increasing substantially. The company raised its full-year guidance due to better-than-expected results but anticipates unfavorable currency effects impacting profitability. Despite trading below fair value estimates, there is no recent substantial insider buying or selling activity noted over the past three months.

  • Navigate through the intricacies of adidas with our comprehensive analyst estimates report here.
  • In light of our recent valuation report, it seems possible that adidas is trading beyond its estimated value.
XTRA:ADS Ownership Breakdown as at Oct 2024

Brockhaus Technologies

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Brockhaus Technologies AG is a private equity firm with a market cap of €281.04 million.

Operations: The company's revenue is primarily derived from its Security Technologies segment, contributing €37.03 million, and Financial Technologies segment, which accounts for €174.59 million.

Insider Ownership: 26.6%

Earnings Growth Forecast: 93% p.a.

Brockhaus Technologies is poised for growth with earnings forecasted to increase 93% annually, surpassing the German market's average. Despite a current net loss of €6.65 million for H1 2024, revenue rose to €109.49 million from €84.64 million year-on-year. The company projects revenues between €220-240 million in 2024 and €290-320 million in 2025, trading significantly below estimated fair value without recent insider trading activity noted over the past three months.

  • Dive into the specifics of Brockhaus Technologies here with our thorough growth forecast report.
  • According our valuation report, there's an indication that Brockhaus Technologies' share price might be on the cheaper side.
XTRA:BKHT Earnings and Revenue Growth as at Oct 2024

Redcare Pharmacy

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Redcare Pharmacy NV operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €2.76 billion.

Operations: The company's revenue is derived from two main segments: DACH, contributing €1.74 billion, and International, generating €391 million.

Insider Ownership: 17.4%

Earnings Growth Forecast: 54.4% p.a.

Redcare Pharmacy shows potential for growth with revenue projected to rise 17% annually, outpacing the German market. Despite a net loss of €12.07 million in H1 2024, sales increased to €1.12 billion from €791.94 million year-on-year. The company raised its full-year sales guidance to between €2.35 billion and €2.5 billion but faces challenges with significant insider selling and past shareholder dilution, trading well below estimated fair value.

  • Click here and access our complete growth analysis report to understand the dynamics of Redcare Pharmacy.
  • According our valuation report, there's an indication that Redcare Pharmacy's share price might be on the expensive side.
XTRA:RDC Ownership Breakdown as at Oct 2024

Make It Happen

  • Gain an insight into the universe of 19 Fast Growing German Companies With High Insider Ownership by clicking here.
  • Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
  • Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Ready For A Different Approach?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include XTRA:ADS XTRA:BKHT and XTRA:RDC.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10